GlobalData on MSN
BD secures FDA 510(k) clearance for EnCor EnCompass system
BD expects to bring the system to market in early 2026.
Zacks Investment Research on MSN
BD gets FDA 510(k) approval for EnCor EnCompass breast biopsy system
Becton, Dickinson and CompanyBDX, popularly known as BD, recently announced that the FDA has granted 510(k) clearance for its ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the U.S.
SALT LAKE CITY--(BUSINESS WIRE)--3M Health Information Systems is expanding its market-leading 3M 360 Encompass System platform to introduce 3M 360 Encompass System – Professional, the industry’s ...
BD (NYSE: BDX) announced today that the FDA granted 510(k) clearance for its EnCore EnCompass breast biopsy and tissue ...
The 3M™ 360 Encompass™ System seamlessly integrates CAC, CDI, concurrent quality metrics, and analytics to capture, analyze, and advance patient information across the continuum of care SANTA CLARA, ...
State-of-the-art, multi-modality breast biopsy system slated to be in the market in early 2026 FRANKLIN LAKES, N.J., Jan. 15, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results